| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO, USA; General Clinical Research Center and the Diabetes Research and Training Center, Washington University School of Medicine, St. Louis, MO, USA
* To whom correspondence should be addressed. E-mail: pcryer{at}wustl.edu.
The relative contributions of the sympathetic nervous system and the adrenal medullae, the two components of the sympathoadrenal system, to the manifestations of hypoglycemia are largely unknown. We tested the hypothesis that the neurogenic symptoms of hypoglycemia are largely the result of sympathetic neural activation. To do so, we quantitated neurogenic symptoms, as well as norepinephrine (NE) kinetics and selected hemodynamic changes, during hyperinsulinemic euglycemic and stepped hypoglycemic clamps in 15 healthy control subjects (Controls) and four bilaterally adrenalectomized patients (ADX). Plasma epinephrine responses to hypoglycemia were virtually absent in ADX as expected. Neurogenic symptom scores increased to higher values during the hypoglycemic compared with the euglycemic clamps in both Controls (P<0.0001) (e.g., final scores of 7.8±1.2 v. 3.0±0.7) and ADX (P<0.0001) (e.g., final scores of 10.8±4.1 v. 2.5±1.0). Plasma NE concentrations (P<0.0001) and systemic NE spillover (P=0.0007) increased during the hypoglycemic compared with the euglycemic clamps in Controls but not in ADX. Similarly, heart rate increased (P=0.0104), diastolic blood pressure decreased (P=0.0003) and forearm blood flow increased (P<0.0001) during the hypoglycemic compared with the euglycemic clamps in Controls but not in ADX. These data indicate that the neurogenic symptoms of hypoglycemia are largely the result of sympathetic neural, rather than adrenomedullary, activation. They also suggest that the plasma norepinephrine and hemodynamic responses to hypoglycemia are largely the result of adrenomedullary, rather that sympathetic neural, activation.
This article has been cited by other articles:
|
|
 |
|
  S. A. Amiel and P. E. Cryer Attenuated Sympathoadrenal Responses, but Not Severe Hypoglycemia, During Aggressive Glycemic Therapy of Early Type 2 Diabetes Diabetes, March 1, 2009; 58(3): 515 - 517. [Full Text] [PDF]
|
|
|
|
|
|
P. E. Cryer The Barrier of Hypoglycemia in Diabetes Diabetes, December 1, 2008; 57(12): 3169 - 3176. [Full Text] [PDF]
|
|
|
|
|
|
V. J. Briscoe, A. C. Ertl, D. B. Tate, S. Dawling, and S. N. Davis Effects of a Selective Serotonin Reuptake Inhibitor, Fluoxetine, on Counterregulatory Responses to Hypoglycemia in Healthy Individuals Diabetes, September 1, 2008; 57(9): 2453 - 2460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. B. Dokken The Parodox of Glycemic Control and Cardiovascular Complications: Sorting Out the Data Diabetes Spectr, July 1, 2008; 21(3): 150 - 152. [Full Text] [PDF]
|
|
|
|
|
|
P. Rossetti, F. Porcellati, N. B. Ricci, P. Candeloro, P. Cioli, G. B. Bolli, and C. G. Fanelli Different Brain Responses to Hypoglycemia Induced by Equipotent Doses of the Long-Acting Insulin Analog Detemir and Human Regular Insulin in Humans Diabetes, March 1, 2008; 57(3): 746 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Arbelaez, W. J. Powers, T. O. Videen, J. L. Price, and P. E. Cryer Attenuation of Counterregulatory Responses to Recurrent Hypoglycemia by Active Thalamic Inhibition: A Mechanism for Hypoglycemia-Associated Autonomic Failure Diabetes, February 1, 2008; 57(2): 470 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Sandoval, B. Gong, and S. N. Davis Antecedent short-term central nervous system administration of estrogen and progesterone alters counterregulatory responses to hypoglycemia in conscious male rats Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1511 - E1516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Canniff, M. S. Smith, D. B. Lacy, P. E. Williams, and M. C. Moore Glucagon secretion and autonomic signaling during hypoglycemia in late pregnancy Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R788 - R795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Geddes, R. E. Warren, A. J. Sommerfield, V. McAulay, M. W.J. Strachan, K. V. Allen, I. J. Deary, and B. M. Frier Absence of Sexual Dimorphism in the Symptomatic Responses to Hypoglycemia in Adults With and Without Type 1 Diabetes Diabetes Care, July 1, 2006; 29(7): 1667 - 1669. [Full Text] [PDF]
|
|
|
|
|
|
L. Jacobson, T. Ansari, and O. P. McGuinness Counterregulatory deficits occur within 24 h of a single hypoglycemic episode in conscious, unrestrained, chronically cannulated mice Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E678 - E684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Chan, W. Zhu, Y. Ding, R. J. McCrimmon, and R. S. Sherwin Blockade of GABAA Receptors in the Ventromedial Hypothalamus Further Stimulates Glucagon and Sympathoadrenal but Not the Hypothalamo-Pituitary-Adrenal Response to Hypoglycemia. Diabetes, April 1, 2006; 55(4): 1080 - 1087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Cryer Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes Diabetes, December 1, 2005; 54(12): 3592 - 3601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Inouye, O. Chan, J. T. Y. Yue, S. G. Matthews, and M. Vranic Effects of diabetes and recurrent hypoglycemia on the regulation of the sympathoadrenal system and hypothalamo-pituitary-adrenal axis Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E422 - E429. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
